Physician profile
Amy Connell
NPI 1871183301
$852.85
in general payments reported to CMS, 2019-2025
14 companies · $247 in 2025
The $247 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $13.83 · 2022: $145 · 2023: $222 · 2024: $225 · 2025: $247.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $694.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $693.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $218.41 | 2022-2025 | |
| Exact Sciences Corporation | $141.94 | 2023-2025 | Cologuard Collection Kit |
| Novo Nordisk INC | $110.62 | 2022-2025 | Ozempic, Rybelsus |
| Cequr Corporation | $66.39 | 2025 | Cequr Simplicity |
| Boston Scientific Corporation | $61.71 | 2024 | Wavewriter Alpha Prime 16 |
| Glaxosmithkline, LLC. | $47.85 | 2022-2023 | Rotarix, Bexsero, Shingrix |
| Astrazeneca Pharmaceuticals LP | $43.20 | 2023-2025 | Airsupra |
| Sanofi-Aventis U.S. LLC | $30.36 | 2022 | |
| Philips North America LLC | $28.84 | 2024 | (Ck7) Extended Holter |
| Lilly USA, LLC | $27.18 | 2021-2022 | |
| Pfizer INC. | $21.70 | 2023 | |
| Insulet Corporation | $21.60 | 2024 | Omnipod |
| Janssen Pharmaceuticals, INC | $19.97 | 2023 | Xarelto |
| Sanofi Pasteur INC. | $13.08 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Connell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.